Fabio Leonessa
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 10%
Papers in
- Co-authors
- Robert Clarke (20 shared papers)Bruce J. Trock (3 shared papers)Todd C. Skaar (6 shared papers)Geoffrey Ling (2 shared papers)Kerrie B. Bouker (2 shared papers)Natalie Davis (2 shared papers)Michael L. McGarvey (2 shared papers)Sándor Kovács (2 shared papers)
- Journals
- Molecular Pharmacology (2 papers)Frontiers in Neurology (2 papers)Breast Cancer Research and Treatment (2 papers)JNCI Journal of the National Cancer Institute (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Fabio Leonessa
33 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Oncology 884
- Cancer Research 243
- Genetics 413
- Toxicology 50
- Molecular Biology 939
Countries citing papers authored by Fabio Leonessa
This map shows the geographic impact of Fabio Leonessa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Leonessa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Leonessa more than expected).
Fields of papers citing papers by Fabio Leonessa
This network shows the impact of papers produced by Fabio Leonessa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Leonessa. The network helps show where Fabio Leonessa may publish in the future.
Co-authors
The 25 scholars most cited alongside Fabio Leonessa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 348 | |
| 2 | 2001 | 327 | |
| 3 | 2003 | 207 | |
| 4 | 2005 | 122 | |
| 5 | 2001 | 116 | |
| 6 | 2012 | 108 | |
| 7 | 1996 | 91 | |
| 8 | Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780). | 2002 | 86 |
| 9 | 1993 | 62 | |
| 10 | Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies. | 1994 | 62 |
| 11 | 2014 | 51 | |
| 12 | 2000 | 34 | |
| 13 | 2001 | 28 | |
| 14 | 1996 | 23 | |
| 15 | 2001 | 21 | |
| 16 | 2022 | 16 | |
| 17 | 1996 | 12 | |
| 18 | Predictive value of some clinical and pathological parameters on upper level axillary lymph node involvement in breast cancer. | 1992 | 11 |
| 19 | 2001 | 10 | |
| 20 | 2020 | 10 |
About Fabio Leonessa
Fabio Leonessa is a scholar working on Oncology, Genetics, Molecular Biology, Epidemiology and Neurology, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (13 papers), Drug Transport and Resistance Mechanisms (10 papers), Traumatic Brain Injury Research (8 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers), Computational Drug Discovery Methods (4 papers), Analytical Chemistry and Chromatography (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Disaster Response and Management (3 papers). The work is most often cited by research in Oncology (884 citations), Cancer Research (243 citations), Genetics (413 citations), Toxicology (50 citations) and Molecular Biology (939 citations). Fabio Leonessa has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Robert Clarke, Bruce J. Trock, Todd C. Skaar, Geoffrey Ling, Kerrie B. Bouker, Natalie Davis, Michael L. McGarvey, Sándor Kovács, Irving W. Wainer and Ann Wright. Their work appears in journals such as Molecular Pharmacology, Frontiers in Neurology, Breast Cancer Research and Treatment, JNCI Journal of the National Cancer Institute and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.